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)-1′-phenyl-1′-(4,5-epoxy-7,8-dihydro-3-hydroxy-6-methoxy-7β-methyl 17-cyclopropylmethyl-6,14-ethenomorphinan-7-yl)-methan-1′-ol (8a) General procedure C was followed using 184 mg of 7a to yield 103 mg of 8a as a white solid: 1 (1′S, 5α, 6R, 7R, 14α)-1′-phenyl-1′-(4,5-epoxy-7,8-dihydro-3-hydroxy-6-methoxy-7β-methyl 17-cyclopropylmethyl-6,14-etheno-morphinan-7-yl)-methan-1′-ol (10a) General procedure C was followed using 161 mg of 9a to yield 56 mg of 10a as a white solid: 1 H NMR (400 MHz, CD 3 OD) δ 7.30-7.18 (m, 5H), 6.59 (AB system, 2H), 6.31 (d, 1H, J = 8.9 Hz), 5.51 (d, 1H, J = 8.9 Hz), 5.02 (s, 1H), 4.66 (s, 1H), 4.45 (d, 1H, J = 6.8 Hz), 3.50-3.40 (m, 3H), 3.38-3.32 (m, 1H), 3.20 (dt, 1H, J a = 14 Hz, J b = 9.7 Hz), 3.16-3.04 (m, 2H), 2.53 (dt, 1H, J a = 14 Hz, J b = 5.2 Hz), 2.16 (AB system, 2H), 2.11 (dd, 1H), 1.28 (s, 3H), 1.21-1.13 (m, 1H), 0.92-0.84 (m, 1H), 0.84-77 (m, 1H), 0.57 (m, 2H). ESIMS: m/z 486 (M+H + , 100) .
By a similar method, the following ligands were prepared: (1′R, 5α, 6R, 7R, 14α)-1′-(2-methylphenyl)-1′-(4,5-epoxy-7,8-dihydro-3-hydroxy-6-methoxy-7β-methyl 17cyclopropylmethyl-6,14-etheno-morphinan-7-yl)-methan-1′-ol (8b) 1 H NMR (400 MHz, CD 3 OD) δ 7.65 (d, 1H, J = 7.3 Hz), 7.25-7.15 (m, 3H), 6.67-6.47 (AB system, 2H), 5.80 (d, 1H, J = 8.9 Hz), 5.26 (s, 1H), 5.08 (s, 1H), 4.23 (d, 1H, J = 6.4 Hz), 3.94 (s, 3H), 3.43 -3.33 (m, 3H), 3.12 (m, 1H), 3.03-2.83 (m, 1H), 2.52 (dt, 1H, J b = 13.7 Hz, J a = 5.4 Hz), 2.27 (s, 3H), 2.16-2.04 (bd, 1H), 1.95 (d, 1H, J = 13.5 Hz), 1.61 (s, 3H), 1.23 (d, 1H, J = 13.5 Hz), 1.07 (m, 1H), 0.82 (m, 1H), 0.72 (m, 1H), 0.49-0.37 (m, 2H). ESIMS: m/z 500 (M+H + , 100) .
(1′S, 5α, 6R, 7R, 14α)-1′-(2-methylphenyl)-1′-(4,5-epoxy-7,8-dihydro-3-hydroxy-6-methoxy-7β-methyl 17cyclopropylmethyl-6,14-etheno-morphinan-7-yl)-methan-1′-ol (10b) 1 H NMR (400 MHz, CD 3 OD) δ 7.16 (d, 2H, J = 8.0 Hz), 7.08 (d, 2H, J = 8.0 Hz), 6.59 (d, 1H, J = 8.0 Hz), 6.54 (d, 1H, J = 8.0 Hz), 6.29 (d, 1H, J = 8.6 Hz), 5.49 (s, 1H J = 9.0 Hz), 5.02 (s, 1H), 4.63 (s, 1H), 4.45 (bd, 1H), 3.47 (s, 3H), 3.46-3.31 (m, 2H), 3.32-3.06 (m, 3H), 2.52 (dt, 1H, J a = 18.0 Hz, J b = 5.0 Hz), 2.30 (s, 3H), 2.14 (s, 2H), 2.10-2.06 (m, 1H), 1.24 (s, 3H), 1.18 (m, 1H) , 0.89-0.78 (m, 2H), 0.51 (m, 2H). ESIMS: m/z 500 (M+H + , 100) .
(1′R, 5α, 6R, 7R, 14α)-1′-(3-methylphenyl)-1′-(4,5-epoxy-7,8-dihydro-3-hydroxy-6-methoxy-7β-methyl 17cyclopropylmethyl-6,14-etheno-morphinan-7-yl)-methan-1′-ol (8c) 1 H NMR (400 MHz, CD 3 OD) δ 7.45 (d, 1H, J = 7.4 Hz), 7.18-7.13 (m, 3H), 6.64-6.57 (AB system, 2H), 6.33 (d, 1H, J = 8. 9 Hz 1′R, 5α, 6R, 7R, 14α)-1′-(4-propylthiophenyl)-1′-(4,5-epoxy-7,8-dihydro-3-hydroxy-6-methoxy-7β -methyl 17cyclopropylmethyl-6,14-etheno-morphinan-7-yl)-methan-1′-ol (8f) 1 H NMR (400 MHz, CDCl 3 ) δ 7.24 (s, 4H), 6.56 (d, 1H, J = 8.0 Hz), 6.44 (d, 1H, J = 8.1 Hz), 1H), 5.55 (d, 1H, J = 8.9 Hz), 5.36 (s, 1H), 5.35 (s, 1H), 5.08 (s, 1H), 4.66 (s, 1H), 3.80 (s, 3H), 3.39 (d, 1H, J = 6.4 Hz), 3.05 (d, 1H, J = 18.3 Hz), 2.88 (t, 2H, J = 7.2 Hz), 1H), 5H) , 2.01 (d, 1H, J = 13.9 Hz), 1.77-1.59 (m, 2H), 1.38 (s, 3H), 1.28-1.16 (m, 1H), 1.01 (t, 3H, J =7.3 Hz), 0.78-0.64 (m, 1H), 0.55-0.38 (m, 2H), 0.14--0.01 (m, 2H). ESIMS: m/z 560 (M+H + , 100) . -7α-formyl-7β-methyl-6,14-endo-ethanotetrahydronorthebaine (11) The aldehyde 4b (500 mg) was dissolved in 15 mL of EtOH. Into this solution was added 30 mg of 10% Pd on carbon. The mixture was shaken in a Parr hydrogenator under 100 psi of H 2 for 12 h. The mixture was filtered and the solvents removed under reduced pressure to yield 510 mg of 11 as a white solid. 1 -6,14-endo-ethano-7β-methyl-nornepenthol (12a) . General procedure A was followed using 515 mg of 11 to yield 336 mg of 12a as white crystals: 1 H NMR (400 MHz, CDCl 3 ) δ 7.36-7.23 (m, 5H), 6.78-6.75 (2d, 1H), 6.61-6.58 ( (1′R, 5α, 6R, 7R, 14α )-1′-phenyl-1′-(4,5-epoxy-7,8-dihydro-3-hydroxy-6-methoxy-7β-methyl 17-cyclopropylmethyl-6,14-ethanomorphinan-7-yl)-methan-1′-ol (15a) . General procedure C was followed using 133 mg of 14 to yield 75 mg of 15a as a white solid: 1 
N-Cyclopropylcarbonyl

